CA9 and breast carcinoma: In line with these results, the same group could demonstrate that full inhibition of CAIX catalytic activity with the imidazole-substituted benzenesulfonamide SLC-149 did not affect growth of MCF10A, UFH-001, and T47D breast cancer cells, indicating a non-catalytic function of CAIX in cancer cell proliferation [118].